Update: 3rd February 2012

TORC Researchers' Grant success

We are pleased to announce that the TORC endorsed study “STandaRd issue trANsfusion versuS Fresher red blood cell Use in intenSive carE (TRANSFUSE)-a randomised controlled trial” was funded by the NHMRC for $2,761,879 over four years.  The TRANSFUSE randomised control trial (RCT) is a multi-centre 5,000 patient trial of fresher red blood cells (RBC) versus standard issue RBC in intensive care patients.  Patients will be recruited beginning mid-2012 in ICUs in Australia and New Zealand (NZ).  The TRANSFUSE-RCT is  a collaboration between the Blood Service, TORC, and the ANZICS-Clinical trials group.  This large RCT will answer this critical question which will have important health policy/transfusion practice implications in Australia and internationally.

BREAKING NEWS:

We are also very pleased to announce that the TORC endorsed INFORM study has been successfully funded by the Canadian Institutes for Health Research for C$1,606,292 over four years.